VanEck Associates’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.6M Buy
196,528
+124,410
+173% +$15.5M 0.02% 387
2026
Q1
$7.66M Buy
72,118
+8,270
+13% +$940K 0.01% 668
2025
Q4
$6.79M Buy
+63,848
New +$6.45M 0.01% 686

Other funds holding ACA

VanEck Associates's ACA Position: Q2 2026 in Review

VanEck Associates increased its Arcosa (ACA) stake by 173% in Q2 2026, buying an estimated $15.5M and bringing the position to 196,528 shares worth $28.6M. The position accounts for 0.02% of the portfolio, ranked #387.

VanEck Associates first reported a position in ACA in Q4 2025 and has held it in 3 quarters since. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • VanEck Associates held 196,528 shares of Arcosa worth $28.6M as of Q2 2026.
  • VanEck Associates bought 124,410 Arcosa shares in Q2 2026, an estimated $15.5M.
  • Arcosa made up 0.02% of VanEck Associates's portfolio in Q2 2026, its #387 holding.
  • VanEck Associates first reported a position in Arcosa in Q4 2025 and has held it in 3 quarters since.
  • 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.